Onkologie

Templeton A.: Level-1-Evidenz für den frühen Einsatz von Abirateron beim metastasierten kastrationsnaiven Prostatakarzinom. Leading Opinions Urologie (2017); 2: 9–12.

Schmid T. Templeton A.: Nierenzellkarzinom– aktuelle Therapieoptionen. OncoMag – Das Schweizer Onkologie- Magazin (2017); 3: 20–3.

Baumann M., Dani S., Dietrich D., Hochstrasser A., Klingbiel D., Mark M., Riesen W., Ruhstaller T., Templeton A., Thürlimann B.: Vitamin D Levels in Swiss Breast Cancer Survivors. Swiss Med Wkly 2017

Tibau A., Molto C., Ocana A., Templeton A., Del Carpio L., Del Paggio J., Barnadas A., Booth C., Amir E.: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration. J Natl Cancer Inst (2017).

Burmeister K., Quagliata L., Andreozzi M., Eppenberger-Castori S., Matter M., Perrina V., Grobholz R., Jochum W., Horber D., Moosmann P., Lehmann F., Köberle D., Ng C., Piscuoglio S., Tornillo L., Terracciano L.: Vascular Endothelial Growth Factor A Amplification in Colorectal Cancer is Associated with Reduced M1 and M2 Macrophages and Diminished PD-1-Expressing Lymphocytes. PLoS One (2017); 12(4): e0175563.

Fehr M., Müller J., Knitel M., Fornaro J., Horber D., Koeberle D., Cerny T., Güller U.: Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients. Clin Colorectal Cancer. 2017; 16(4): 343–8.

Ribnikar D., Goldvaser H., Ocana A., Templeton A., Seruga B., Amir E.: Reporting of Randomized Trials in Common Cancers in the Lay Media. Oncology. 2017 Nov 18.

Gonzalez-Conchas G., Rodriguez-Romo L., Hernandez Barajas D., Gonzalez-Guerrero J., Rodriguez-Fernandez I., Verdines-Perez A., Templeton A., Ocana A., Seruga B., Tannock I., Amir E., Vera-Badillo F.: Epidermal Growth Factor Receptor Overexpression and Outcomes in Early Breast Cancer: A Systematic Review and a Meta-Analysis. Cancer Treat Rev. 2017 Oct 31; 62: 1–8.

Klein S., Kohler S., Krüerke D., Templeton A., Weibel A., Haraldsson E., Nahm M., Wolf U.: End-of-Life Experiences: A Survey Amongst Physicians and Nurses in a Hospital for Anthroposophically Extended Medicine. Complement Med Res. 2017 Oct 26.

Niraula S., Templeton A., Vera-Badillo F., Dodd A., Nugent Z., Joshua A., Tannock I.: Suppression of Bone Turnover Following Zoledronic Acid in Men with Metastatic Castration-Resistant Prostate Cancer. Future Science OA. 2017 Oct 20.

Goldvaser H., AlGorashi I., Ribnikar D., Seruga B., Templeton A., Ocana A., Amir E.: Efficacy of Extended Adjuvant Therapy with Aromatase Inhibitors in Early Breast Cancer among Common Clinicopathologically-DefinedSubgroups: A Systematic Review and Meta-Analysis. Cancer Treat Rev. 2017 Sep; 59: 46–53.

Diem S., Schmid S., Krapf M., Flatz L., Born D., Jochum W., Templeton A., Früh M.: Neutrophilto-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients with Non-Small Cell Lung Cancer (NSCLC) treated with Nivolumab. Lung Cancer. 2017 Sep; 111: 176–81.

Goldvaser H., Ribnikar D., Fazelzad R., Seruga B., Templeton A., Ocana A., Amir E.: Influence of Non-Measurable Disease on Progression-Free Survival in Patients with Metastatic Breast Cancer. Cancer Treat Rev. 2017 Sep; 59: 46–53.

Ocana A., Nieto-Jiménez C., Pandiella A., Templeton A.: Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Mol Cancer. 2017 Aug 15; 16(1): 137.

Kulkarni G., Hermanns T., Wie Y., Bhindi B., Satkunasivam R., Athanasopoulos P., Bostrom P., Kuk C., Li K., Templeton A., Sridhar S., van der Kwast T., Chung P., Bristow R., Milosevic M., Warde P., Fleshner N., Jewett M., Bashir S., Zlotta A.: A Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. J Clin Oncol. 2017 Jul 10; 35(20): 2299–305.

Adam R., Diez-Gonzalez L., Ocana A., Seruga A., Amir E., Templeton A.: Prognostic Role of Telomere Length in Malignancies: A Meta-Analysis and Meta-Regression. Exp Mol Pathol. 2017 May 12.

Barnes T., Amir E., Templeton A., Gomez Garcia S., Navarro B., Seruga B., Ocana A.: Efficacy, Safety, Tolerability and Price of Newly Approved Drugs in Solid Tumors. Cancer Treat Rev. 2017 May; 56: 1–7.

Tibau A., Diez-Gonzalez L., Navarro B., Templeton A., Seruga B., Pandiella A., Amir E., Ocana A.: Impact of Availability of Companion Diagnostics on Clinical Development of Anti-Cancer Drugs. Mol Diagn Ther. 2017 Feb 28.

Ethier J., Desautels D., Templeton A., Oza A., Amir E., Lheureux S.: Is the Neutrophil-to-Lymphocyte Ratio Prognostic of Survival Outcomes in Gynecologic Cancers? A Systematic Review and Meta-Analysis. Gynecol Oncol. 2017 Feb 17.

Ethier J., Desautels D., Templeton A., Shah P., Amir E.: Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Breast Cancer: A Systematic Review and Meta-Analysis. Breast Cancer Res. 2017 Jan 5; 19(1): 2.

Dearnaley D., Inge van Oort I., Templeton A.: Metastatic Prostate Cancer. In: Summary of Science of Practice – Metastatic Prostate Cancer. Published by Mirrors of Medicine eHIMS bvba, Lier, Belgium 2016: 7–34

Vera-Badillo F., Napoleone M., Krzyzanowska M., Alibhai S., Chan A., Ocana A., Templeton A., Seruga B., Amir E., Tannock I.: Honorary and Ghost-Authorship in Reports of Randomized Clinical Trials in Oncology Eur J Cancer. Oct 2016:66:1–8

Khoja L., Atenafu E., Ye Q, Templeton A., Chappell M., Hogg D., Butler M., Joshua A.: The full blood count as a biomarker of outcome and toxicity in ipilimumab treated cutaneous metastatic melanoma. Cancer Cancer Med. Oct 2016: 5(10): 2792–2799

Sonpavde G., Pond G. R., Templeton A., Kwon E., De Bono J.: Impact of single agent daily prednisone on outcomes in men with metastatic castrationresistant prostate cancer. Prostate Cancer Prostatic Dis. 27 Sep 2016

Theurich S., Rothschild S., Hoffmann M., Fabri M., Sommer A., Garcia-Marquez M., Thelen M., Schill C., Merki R., Schmid T., Koeberle D., Zippelius A., Baues C., Mauch C., Tigges C., Kreuter A., Borggrefe J., von Bergwelt-Baildon
M., Schlaak M.: Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma. Cancer Immunol Res. 2 Sep 2016: 4(9): 744–754

Hess V., Winterhalder R., von Moos R., Widmer L., Stocker P., Jermann M., Herrmann R., Koeberle D.: Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal
Cancer: Long-Term Outcome. Clin Colorectal Cancer. 30 Jul 2016: pii: S1533–0028(16)30115-3

Srikanthan A., Vera-Badillo F., Ethier J. L., Goldstein R., Templeton A. J., Ocana A., Seruga B., Amir E.: Evolution in the Eligibility Criteria of Randomized Controlled Trials for Systemic Cancer Therapies. Cancer Treatment Reviews 2016: 43: 67–73

Koechlin L., Zettl A., Koeberle D., von Flüe M., Bolli M.: Metastatic Inflammatory Myofibroblastic Tumor of the Spleen: A Case Report and Review of the Literature. Case Rep Surg. 2016 Ethier J. L., Desautels D., Templeton A. J., Shah P., Amir E.: Prognostic Role of Neutrophil- to-Lymphocyte Ratio in Breast Cancer: A Systematic Review and Meta- Analysis. Breast Cancer Research 2016

Tannock I., Amir E., Booth C. M., Niraula S., Ocana A., Seruga B., Templeton A., Vera-Badillo F.: The relevance of randomized controlled trials to clinical practice. Lancet Oncol. Dec 2016: 17(12): e560–e567

Matter-Walstra K., Schwenkglenks M., Betticher D., von Moos R., Dietrich D., Baertschi D., Koeberle D.: Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06). Clin Colorectal Cancer. Dec 2016:15(4): 314–320.e2

Arnet I., Schacher S., Balmer E., Koeberle D., Hersberger K.: Poor adhesion of fentanyl transdermal patches may mimic end-ofdosage failure after 48 hours and prompt early patch replacement in hospitalized cancer pain patients. J Pain Res. 9 Nov 2016: 9:993–999

Vera-Badillo F., Marc Napoleone M., Krzyzanowska M., Alibhai S., Chan A. W., Ocana A., Seruga B., Templeton A., Amir E., Tannock I.: Bias in Reporting of Randomized Clinical Trials in Oncology. Eur J Cancer. Jul 2016: 61: 29–35

Zumstein V., Vinzens F., Zettl A., Heinimann K., Koeberle D., von Flüe M., Bolli M.: Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients. Swiss Med Wkly.
6 May 2016: 146

Templeton A., Diez Gonzalez L., Vera-Badillo F., Tibau A., Goldstein R., Šeruga B., Srikanthan A., Pandiella A., Amir E., Ocana A.: Interaction between hormonal receptor status, age and survival in patients with BRCA1/2 germline mutations: A systematic review and metaregression. PLoS One. 5 May 2016:11(5)

Seruga B., Templeton A., Vera-Badillo F., Ocana A., Amir E., Tannock I.: Under-reporting of harm in clinical trials. Lancet Oncol. May 2016: 17(5): e209–219

Koeberle D., Dufour J., Demeter G., Li Q., Ribi K., Samaras P., Saletti P., Roth A., Horber D., Buehlmann M., Wagner A. D., Montemurro M., Lakatos G., Feilchenfeldt J., Peck-Radosavljevic M., Rauch D., Tschanz B., Bodoky G.; Swiss Group for Clinical Cancer Research (SAKK): Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Ann Oncol. May 2016: 27(5): 856–861

Ocaña A., Pérez-Peña J., Alcaraz-Sanabria A., Sánchez-Corrales V., Templeton A., Seruga B., Pandiella A., Amir E.: In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases. Oncotarget. 16 Mar 2016

Tibau A., Ocana A., Anguera G., Seruga B., Templeton A., Barnadas A., Amir E.: Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the U.S. Food and Drug Administration. JAMA Oncol. 3 Mar 2016

Niraula S., Templeton A., Vera-Badillo F., Joshua A., Sridhar S., Knox J., Cheung P., Yip P., Dodd A., Nugent Z., Tannock I.: Testosterone-Guided Schedule of Androgen Deprivation Therapy as an Alternative to a Fixed Schedule in Management of Prostate Cancer. Prostate. Feb 2016: 76(2): 235–242

Ocana A., Díez-González L., Templeton A., Vera-Badillo F., José Escribano M., Serrano G., Sánchez-Corrales V., Seruga B., Pandiella A., Amir E.: Circulating DNA and survival in solid tumors. Cancer Epidemiol Biomarkers Prev. Feb 2016: 25(2): 399–406

Ocaña A., Pérez-Peña J., Díez-González L., Sánchez-Corrales V., Templeton A., Seruga B., Amir E., Pandiella A.: Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer. Breast Cancer Res Treat. Feb 2016: 156(1): 1–8

Strasser F., Blum D., von Moos R., Cathomas R., Ribi K., Aebi S., Betticher D., Hayoz S., Klingbiel D., Brauchli P., Haefner M., Mauri S., Kaasa S., Koeberle D.; Swiss Group for Clinical Cancer Research (SAKK): The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Ann Oncol. Feb 2016: 27(2): 324–332

Templeton A., Knox J. , Lin X., Simantov R., Xie W., Lawrence N., Broom R., Fay A., Rini B., Donskov F.,
Bjarnason G. A., Smoragiewicz M., Kollmannsberger C., Kanesvaran R., Alimohamed N., Hermanns T., Wells J., Amir E., Choueiri T., Heng D.: Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy. Eur Urol. 25 Feb 2016

Bhindi B., Hermanns T., Wei Y., Yu J., Richard P., Wettstein M., Templeton A. J., Li K., Sridhar S., Jewett M., Fleshner N., Zlotta A., Kulkarni G.: Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy. Br J Cancer. 19 Jan 2016 : 114(2): 207–212

Gautschi O., Milia J., Cabarrou B., Bluthgen M.V., Besse B., Smit E.F., Wolf J., Peters S., Früh M., Köberle D., Oulk-houir Y., Schuler M., Curioni-Fontecedro A., Huret B., Kerjouan M., Michels S., Pall G., Rothschild S., Schmid-Bindert G., Scheffler M., Veillon R., Wannesson L., Diebold J., Zalcman G., Filleron T., Mazières J.: Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort. J Thorac Oncol. Oct 2015: 10(10): 1451–7

Harms W., Geretschläger A., Cescato C., Buess M., Köberle D., Asadpour B.: Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care (Basel). Aug 2015: 10(4): 265–71

Rajski M., Saaf A., Buess M.: BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas. BMC Med Genomics. Apr 2015: 29; 8:16: 1–12

Köberle D., Betticher D.C., von Moos R., Dietrich D., Brauchli P., Baertschi D., Matter K., Winterhalder R., Borner M., Anchisi S., Moosmann P., Kollar A., Saletti P., Roth A., Frueh M., Kueng M., Popescu R.A., Schacher S., Hess V., Herrmann R.: Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Ann Oncol. Apr 2015: 26(4): 709–14

Bergmann L., Maute L., Heil G., Rüssel J., Weidmann E., Köberle D., Fuxius S., Weigang-Köhler K., Aulitzky W.E., Wörmann B., Hartung G., Moritz B., Edler L., Burkholder I., Scheulen M.E., Richly H.: A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Re-search-EWIV. Eur J Cancer. Jan 2015: 51(1): 27–36 

Radioonkologie

Grosser K., Schulte A., Harms W.: An Electronically Configurable Checklist Program for Quality Control of RT Treatment Planning. Radiotherapy and Oncology; Volume 123, Supplement 1, 2017 May; S563.

Herraiz Lablanca M., Paul S., Chiesa M., Grosser K., Harms W.: Evaluation of an Autosegmentation Software for Definition of Organs at Risk in Radiotherapy. Radiotherapy and Oncology; Volume 123, Supplement 1, 2017 May; S554.

Krug D., Baumann R., Budach W., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M., Sautter-Bihl M., Sedlmayer F., Souchon R., Wenz F., Sauer R.; Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO): Current Controversies in Radiotherapy for Breast Cancer. Radiat Oncol. 2017 Jan 23; 12(1): 25.

Harms, W., Budach, W., Dunst, J. et al.: DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol 2016: 192: 199–208

Harms W., Geretschläger A., Cescato C., Buess M., Köberle D., Asadpour B.: Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care (Basel). Aug 2015: 10(4): 265–71
 

Asadpour B., Harms W.: Von der adjuvanten zur neoadjuvanten Radio-/Radiochemotherapie: Multimodale Therapie des Rektumkarzinoms. InFo Onkologie & Hämatologie. 2015: 8: 1–6
 

Budach W., Matuschek C., Bölke E., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M.D., Sautter-Bihl M.L., Sedlmayer F., Souchon R., Wenz F., Sauer R.: Breast Cancer Expert Panel of German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 2015: 191: 623–33
 

Rochet N., Lindel K., Katayama S., Schubert K., Herfarth K., Schneeweiss A., Sohn C., Harms W., Debus J.: Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer: four-year outcomes. Strahlenther Onkol. 2015: 191: 582–9

Innere Medizin, Endokrinologie mit Ernährungszentrum

Peterli R., Wölnerhanssen B., Vetter D., Nett P., Gass M., Borbély Y., Peters T., Schiesser M., Schultes B., Beglinger C., Drewe J., Bueter M.: Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg. 2017 Mar; 265(3): 466–73.

Gillis C., Roque P.S., Bläss J., Urwyler A., Schepperle H., Kunz G., Peters T., Schricker T., Wykes L., Kopp Lugli A.: High-Dose Amino Acid Administration Achieves an Anabolic Response in Type 2 Diabetic Patients that Is Independent of Glycaemic Control: A Randomized Clinical Trial. Clin Nutr. 2017 May 3; pii: S0261–5614(17)30155–3.

Peters T.: Fructose nützlich oder schädlich: immer eine Frage der Dosis. Praxis 2016: 105(13): 1–1

Schneider R., Gass J., Kern B., Peters T., Slawik M., Gebhart M., Peterli R.: Linear compared to circular stapler anastomosis in laparoscopic Roux-Y gastric bypass leads to comparable weight loss with fewer complications: a matched pair study. Langenbecks Arch Surg May 2016 (401): 307–313

Wölnerhanssen B., Meyer-Gerspach A., Peters T., Beglinger C., Peterli R.: Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls. Surg Obes Relat Dis. Aug 2016: 12(7): 1320–1327

Wehrum T., Hagenlocher P., Lodemann T., Vach W., Dragonu I., Hennemuth A., von Zur Mühlen C., Stuplich J., Ngo T., Harloff A.: Age dependence of pulmonary artery blood flow measured by 4D flow cardiovascular magnetic resonance: results of a populationbased study. J Cardiovasc Magn Reson. 31 May 2016: 18(1)31

Gebhart M.: Praxisrelevante Probleme und Komplikationen nach bariatrischen Operationen.
Minireview. PRAXIS. Dez 2015: 104: 1379–1385

Wölnerhanssen B., Meyer-Gerspach A., Peters T., Beglinger C., Peterli R.: Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls. Surg Obes Relat Dis. Nov 2015: in press

Peters T.: Ernährung bei chronisch entzündlichen Darmerkrankungen. Falk Gastro-Kolleg Darm: 9/2015

Schneider J., Peterli R., Gass M., Slawik M., Peters T., Wölnerhanssen B.K.: Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass lead to equal changes in body composition and energy metabolism 17 months postoperatively: a prospective randomized trial. Surg Obes Relat Dis. Jul 2015: in press

Lindinger P., Christe M., Eberle A., Kern B., Peterli R., Peters T., Jayawardene K., Fearnley I., Walker J.: Important mitochondrial proteins in human omental adipose tissue show reduced expression in obesity. Data Brief. Apr 2015: 23(4): 40-3 J Proteomics. Jun 2015: 124: 79–87

Bauchzentrum

Peterli R., Wölnerhanssen B., Peters T., Vetter D., Kröll D., Borbély Y., Schultes B., Beglinger C., Drewe J., Schiesser M., Nett P., Bueter, M.: Effect of Laparoscopic Sleeve Gastrectomy vs. Laparoscopic Rouxen-Y Gastric Bypass on Weight Loss in Patients with Morbid Obesity. The SM-BOSS Randomized Clinical Trial. JAMA, accepted for publication 12/2017.

Dainty A., Hunt M., Holtham E., Kinsella P., Timmons S., Fox M., Callaghan P.: The Feasibility of Nurse Delivered, Low-Intensity Cognitive Behavioural Therapy for Irritable Bowel Syndrome. Gastrointestinal Nursing (2017); 15(9).

Ang D., Fox M.: Utility of High- Resolution Esophageal Manometry and Ambulatory pH-Impedance Measurement in the Diagnosis of Gastro-Esophageal Reflux Disease and Hiatus Hernia In: Hiatal Hernia Surgery – an Evidence-Based Approach. 1st Edition 2017. Ed.: Memon M.

Ang D., Fox M.: Achalasia and Esophageal Outlet Obstruction. In: Gastrointestinal Motility Disorders: A Point-of-Care Clinical Guide, 1st Edition 2017. Ed.: Shaker R., Bardan S. 

Roman S., Gyawali C., Savarino E., Yadlapati R., Zerbib F., Wu J., Vela M., Tutuian R., Tatum R., Sifrim D., Keller J., Fox M., Pandolfino J., Bredenoord A.: Ambulatory Reflux Monitoring for Diagnosis of Gastroesophageal Reflux Disease: Update of the Porto Consensus and Recommendations from an International Consensus Group. Neurogastroenterol Motil. (2017).Heinrich H., Fox M.: Diagnostic and Treatment Approaches: Functional Anorectal Disorders. In: Functional GI Disorders: A biopsychosocial treatment approach, 1st Edition 2017. Ed.: Knowles S., Stern J.,
Hebbard G.

Ang D., Fox M.: Utility of High- Resolution Esophageal Manometry and Ambulatory pH-Impedance Measurement in the Diagnosis of Gastro-Esophageal Reflux Disease and Hiatus Hernia. In: Hiatal Hernia Surgery – an Evidence-Based Approach, 1st Edition 2017.

Fox M., Halama M., Vavricka S.: Gastroösophageale Refluxerkrankung: Was tun, wenn PPI nicht vertragen oder nicht gewünscht sind? Alginate im Step-down- Prozess und als Monotherapie. Hausarzt Praxis (2017).

Fox M., Halama M., Vavricka S.: Gastroösophageale Refluxerkrankung: Was tun, wenn PPI nicht wirksam sind? Add-on-Therapie mit Alginaten. Hausarzt Praxis (2017).

Corsetti M., Fox M.: Recent Advances in Understanding and Management of Dyspepsia Faculty of 1000. (2017); in publication. Fox M., Halama M., Vavricka S.: Gastroösophageale Refluxerkrankung: Diagnostische und therapeutische Möglichkeiten Hausarzt Praxis (2017).

Bluemel S., Menne D., Milos G., Goetze O., Fried M., Schwizer W., Fox M., Steingoetter A.: Relationship of Body Weight with Gastrointestinal Motor and Sensory Function: Studies in Anorexia Nervosa and Obesity. BMC Gastroenterol. (2017); 17(1): 4.

Gyawali C., Roman S., Bredenoord A., Fox M., Keller J., Pandolfino J., Sifrim D., Tatum R., Yadlapati R., Savarino E.; International GERD Consensus Working Group: Classification of Esophageal Motor Findings in Gastroesophageal Reflux Disease: Conclusions from an Inter national Consensus Group. Neuro gastroenterol Motil. 2017 Dec; 29(12).

Savarino E., Bredenoord A., Fox M., Pandolfino J., Roman S., Gyawali C.; International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: Advances in the Physiological Assessment and Diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2017 Nov; 14(11): 665-76.

Steinemann D., Müller P., Billeter A., Bruckner T., Ulrich A., Müller-Stich B.: Surgery is Essential in Squamous Cell Cancer of the Rectum. Langenbecks Arch Surg. 2017 Nov; 402(7): 1055–62. Savarino E., Bredenoord A., Fox M., Pandolfino J., Roman S., Gyawali C., International Working Group for Disorders of Gastrointestinal Motility and Function: Current Concepts on Mechanisms and Evaluation of Gastroesophageal Reflux Disease: a Consensus Statement. Nat. Rev. Gastroenterol. Hepatol. 2017 Nov; 14(11): 665–76.

Kahrilas P., Bredenoord A., Fox M., Gyawali C., Roman S., Smout A., Pandolfino J., International Working Group for Disorders of Gastrointestinal Motility and Function: Advances in the Diagnosis and Management of Esophageal Motility Disorders in the Era of High-Resolution Manometry. Nat. Rev. Gastroenterol. Hepatol. 2017; 2017 Nov; 14(11): 677–88.

Misselwitz B., Fox M.: What is Normal and Abnormal in Lactose Digestion? Lancet Gastroenterol Hepatol. 2017 Oct; 2(10): 696–7.

Müller P., Steinemann D., Nickel F., Chinczewski L., Müller-Stich B., Linke G., Z’graggen K.: Transduo -denal-Transpapillary Endopancreatic Surgery with a Rigid Resectoscope: Experiments on Ex Vivo, In Vivo Animal Models and Human Cadavers. Surg Endosc. 2017 Oct; 31(10): 4131–5.

Steinemann D.: Abdominal Wall Expanding System Obviates the Need for Lateral Release in Giant Incisional Hernia and Laparostoma. Surg Innov. 2017 Oct; 24(5): 455–61.  

Vinzens F., Kilchenmann A., Zumstein V., Slawik M., Gebhart M., Peterli R.: Long-Term Outcome of Laparoscopic Adjustable Gastric Banding (LAGB): Results of a Swiss Single-Center Study of 405 Patients with up to 18 Years’ Follow-up. Surg Obes Relat Dis. 2017 Aug; 13(8): 1313–9. Eucker D., Zerz A.,

Roman S., Gyawali C., Savarino E., Yadlapati R., Zerbib F., Wu J., Vela M., Tutuian R., Tatum R., Sifrim D., Keller J., Fox M., Pandolfino J., Bredenoord A.; GERD consensus group: Ambulatory Reflux Monitoring for Diagnosis of Gastroesophageal Reflux Disease: Update of the Porto Consensus and Recommendations from an International Consensus Group. Neurogastroenterol Motil. 2017 Oct; 29(10): 1–15. 

Ang D., Misselwitz B., Hollenstein M., Knowles K., Wright J., Tucker E., Sweis R., Fox M.: Diagnostic Yield of High-Resolution Manometry with a Solid Test Meal for Clinically Relevant, Symptomatic Oesophageal Motility Disorders: Serial Diagnostic Study. Lancet Gastroenterol Hepatol. 2017 Sep; 2(9): 654–61.

Hollenstein M., Thwaites P., Bütikofer S., Heinrich H., Sauter M., Ulmer I., Pohl D., Ang D., Eberli D., Schwizer W., Fried M., Distler O., Fox M., Misselwitz B.: Pharyngeal Swallowing and Esophageal Motility During a Solid Test Meal Assessed by High-Resolution Manometry in Healthy Volunteers and Patients with Major Motility Disorders. Lancet Gastroenterol Hepatol. 2017 Sep; 2(9): 644–53.

Sweis R., Heinrich H., Fox M.: Variation in High-Resolution Manometry Methodology in Clinical Practice: Results from an International Survey. Neurogastroenterol Motil. 2017 Sep 25.

Sauter M., Vavricka S., Keilholz G., Heinrich H., Winder T., Kranzbühler H., Lombriser N., Misselwitz B.: Surveillance of Anal Carcinoma after Radiochemotherapy: A Retrospective Analysis of 80 Patients. Strahlenther Onkol. 2017 Aug; 193(8): 639–47.

Wölnerhanssen B., Moran A., Burdyga G., Meyer-Gerspach A., Peterli R., Manz M., Thumshirn M., Daly K., Beglinger C., Shirazi-Beechey S.: Deregulation of Transcription Factors Control ling Intestinal Epithelial Cell Differentiation; A Predisposing Factor for Reduced Enteroendocrine Cell Number in Morbidly Obese Individuals. Sci Rep. 2017 Aug 15; 7(1): 8174.

Steinemann D., Zerz A., Müller P., Sauer P., Schaible A., Lasitschka F., Schwarz A., Müller-Stich B., Linke G.: Laparoscopic Transgastric Circumferential Stapler-Assisted vs. Endoscopic Esophageal Mucosectomy in a Porcine Model. Endoscopy. 2017 Jul; 49(7): 668–74. Müller P., Senft J., Gath P., Steinemann D., Nickel F., Billeter A., Müller-Stich B., Linke G.: Transrectal Rigid-Hybrid NOTES Cholecystectomy Can Be Performed without Peritoneal Contamination: a Controlled Porcine Survival Study. Surg Endosc. 2017 Aug 10.

Müller P., Steinemann D., Sauer P., Z’graggen K., Linke G., Müller-Stich B.: Balloon Dilatation of the Minor Duodenal Papilla Up to 4 mm is Safe in a Porcine Model. Surg Laparosc Endosc Percutan Tech. 2017 Aug; 27(4): e44–7.

Steinemann D., Müller P., Probst P., Schwarz A., Büchler M., Müller- Stich B., Linke G.: Meta-Analysis of Hybrid Natural-Orifice Transluminal Endoscopic Surgery versus Laparoscopic Surgery. Br J Surg. 2017 Jul; 104(8): 977–89.

Governa V., Trella E., Mele V., Tornillo L., Amicarella F., Cremonesi E., Muraro M., Xu H., Droeser R., Däster S., Bolli M., Rosso R., Oertli D., Eppenberger- Castori S., Terracciano L., Iezzi G., Spagnoli G.: The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer. Clin Cancer Res. 2017 Jul 15; 23(14): 3847–58.

Parker H., Tucker E., Blackshaw E., Hoad C., Marciani L., Perkins A., Menne D., Fox M.: Clinical Assessment of Gastric Emptying and Sensory Function Utilizing Gamma Scintigraphy: Establishment of Reference Intervals for the Liquid and Solid Components of the Nottingham Test Meal in Healthy Subjects. Neurogastroenterol Motil. 2017 Jun 6.

Steinemann D., Zerz A., Lamm S.: Implementation of Hybrid-NOTES Sigmoidectomy for Diverticular Disease: In a Center for Minimally Invasive Surgery. Chirurg. 2017 Jun; 88(6): 518–24.

Gyawali C., Savarino E., Bredenoord A., Fox M., Pandolfino J., Keller J., Sifrim D., Tatum R., Yadlapati R., Roman S.: Classification of Esophageal Motor Findings in Gastroesophageal Reflux Disease: Conclusions from an International Consensus Group. Neurogastroenterol Motil. 2017 May 24.

Parker H., Curcic J., Heinrich H., Sauter M., Hollenstein M., Schwizer W., Fox M.: What to Eat and Drink in the Festive Season: A European, Observational, Cross-Sectional Study. Eur J Gastroenterology and Hepatology 2017 May; 29(5): 608–14.

Müller P., Müller S., Steinemann D., Pärli M., Moltzahn F., Schmid S., Z’graggen K.: Case-Matched Study of Lesser versus Greater Curvature Approach in Laparoscopic Warshaw Pancreatectomy. Am J Surg. 2017 Apr; 213 (4): 711–7.

Peterli R., Wölnerhanssen B., Vetter D., Nett P., Gass M., Borbély Y., Peters T., Schiesser M., Schultes B., Beglinger C., Drewe J., Bueter M.: Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass or Sleeve Study (SM-BOSS). Ann Surg. 2017 Mar; 265(3): 466–73.

Roman S., Holloway R., Keller J., Herbella F., Zerbib F., Xiao Y., Bernard L., Bredenoord A., Bruley des Varannes S., Chen M., Fox M., Kahrilas P., Mittal R., Penagini R., Savarino E., Sifrim D., Wu J., Decullier E., Pandolfino J., Mion F.: Validation of Criteria for the
Definition of Transient Lower Esophageal Sphincter Relaxations Using High-Resolution Manometry. Neuro gastroenterol Motil. 2017 Feb; 29(2). 

Jasper D., Freitas-Queiroz N., Hollenstein M., Misselwitz B., Layer P., Navarro-Rodriguez T., Fox M., Keller J.: Prolonged Measurement Improves the Assessment of the Barrier Function of the Esophagogastric Junction by High-Resolution Manometry. Neurogastroenterol Motil. 2017 Feb; 29(2). 

Steinemann D., Zerz A., Adamina M., Brunner W., Keerl A., Nocito A., Scheiwiller A., Spalinger R., Vorburger S., Lamm S.: Single-Incision and Natural Orifice Translumenal Endoscopic Surgery in Switzerland. World J Surg. 2017 Feb; 41(2): 449–56. 

Carrington E., Heinrich H., Knowles C., Rao S., Fox M., Scott M. with IAPWG: Methods of Anorectal Manometry Vary Widely in Clinical Practice: An International Survey. Neurogastroenterol Motil. 2017 Jan 18. 

Tampakis A., Tampaki E., Posabella A., Zettl A., Kouraklis G., von Flüe M., Guenin M.: KRAS Mutations with no GNAS Mutations in an Intraductal Papillary Mucinous Neoplasm: Are there Common Pathways with Pancreatic Ductal Adenocarcinoma? Lessons from an Extended IPMN, Covering the Entire Pancreas. Pancreas. 2017 Jan; 46(1): e5–7. 

Sauter M., Vavricka S.: BarrettÖsophagus, Diagnostik, Surveillance und Therapie. Der informierte Arzt. 01/2017. 

Ang D., Hollenstein M., Misselwitz B., Knowles K., Wright J., Tucker E., Sweis R., Fox M.: Rapid Drink Challenge in High-Resolution Manometry: An Adjunctive Test for Detection of Esophageal Motility Disorders. Neurogastroenterol Motil. 2017 Jan; 29(1). 

Däster S., D. Soysal S. D., Koechlin L., Stoll L., Peterli R., von Flüe M., Ackermann C.: Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization. Langenbecks Arch Surg. Sep 2016: 401: 787–795

Gruber M., Füglistaler I., Zettel A., Fox M., Manz M.: An Unusual Cause of Rectal Stenosis. Case Rep Gastroenterol. 9 Aug 2016: 10(2): 406–409 Wölnerhanssen B., Meyer-Gerspach A., Peters T., Beglinger C., Peterli R.: Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls. Surg Obes Relat Dis. Aug 2016: 12(7): 1320–1327

Kobe A., Posabella A., Tampakis A., von Flüe M., Bolli M.: Crohn‘s disease-associated large and small bowel adenocarcinoma with peritoneal carcinomatosis: two case reports. Int J Colorectal Dis. Aug 2016 : 31(8): 1491–1492

Gruber M., Füglistaler I., Zettel A., Fox M., Manz M.: An Unusual Cause of Rectal Stenosis. Case Rep Gastroenterol. 9 Aug 2016: 10(2): 406–409

Wölnerhanssen B., Cajacob L., Keller N., Doody A., Rehfeld J. F., Drewe J., Peterli R., Beglinger C., Meyer-Gerspach A.: Gut hormone secretion, gastric emptying and glycemic responses to erythritol and xylitol in lean and obese subjects. Am J Physiol Endocrinol Metab. 1 Jun 2016: 310(11): E1053–61

Vinzens F., Zumstein V., Bieg C., Ackermann C.: Two similar cases of elderly women with moderate abdominal pain and pneumoperitoneum of unknown origin: a surgeon’s successful conservative management. BMJ Case Rep. 15 May 2016

Zumstein V., Vinzens F., Zettl A., Heinimann K., Koeberle D., von Flüe M., Bolli M.: Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients. Swiss Med Wkly. 6 May 2016: 146

Schneider R., Gass J., Kern B., Peters T., Slawik M., Gebhart M., Peterli R.: Linear compared to circular stapler anastomosis in laparoscopic Roux-Y gastric bypass leads to comparable weight loss with fewer complications: a matched pair study. Langenbecks Arch Surg May 2016 (401): 307–313

Schneider J., Peterli R., Gass M., Slawik M., Peters T., Wölnerhanssen B.: Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass lead to equal changes in body composition and energy metabolism 17 months postoperatively: a prospective randomized trial. Surg Obes Relat Dis. Mar–Apr 2016 : 12(3): 563–570

Vavricka S., Sulz M., Degen L., Rechner R., Manz M., Biedermann L., Beglinger C., Peter S., Safroneeva E., Rogler G., Schoepfer A.: Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy. Mar 2016: 48(3): 256–262

Heinrich H., Misselwitz B., Pohl D., Fox M.: Erstlinienmanagement bei gastroösophagealem Reflux: Diät und Therapie mit rezeptfreien Medikamenten. Der Gastroenterologe, Mar 2016: 11(2): 119–124

Kraljevic M., Peterli R.: Komplikationen nach bariatrischer Chriurgie. Leading Opinions Innere Medizin 2/2016: 77–80

Peterli R., Wölnerhanssen B., Vetter D., Nett P., Gass M., Borbely Y., Peters T., Schiesser M., Schultes B., Beglinger C., Drewe J., Bueter, M.: Laparoscopic Sleeve Gastrectomy versus Roux-Y-Gastric Bypass for Morbid Obesity – 3-Year-Outcomes of the prospective randomized Swiss Multicentre Bypass Or Sleeve Study (SM-BOSS). Accepted for publication Ann Surg. 2016

Koechlin L., Zettl A., Koeberle D., von Flüe M., Bolli M.: Metastatic Inflammatory Myofibroblastic Tumor of the Spleen: A Case Report and Review of the Literature. Case Rep Surg. 2016: 2016

Jasper D., Freitas N., Hollenstein M., Misselwitz B., Layer P., Navarro T., Fox M., Keller J.: Prolonged measurement improves the assessment of the barrier function of the esophago-gastric junction by high resolution manometry. Neurogastroenterol Motil. 2016

Roman, S., Holloway, R., Keller, J., Herbella, F., Zerbib, F., Xiao, Y., Bredenoord, A., Bruley des Varannes, S., Chen, M., Fox, M., Kahrilas, P., Mittal, R., Penagini, R., Savarino, E., Sifrim, D., Wu, J., Decullier, E., Pandolfino, J., Mion, F.: Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry. Neurogastroenterol Motil. 2016

Ang D., Hollenstein M., Misselwitz B., Knowles K., Wright J., Tucker E., Sweis R., Fox M.: Rapid Drink Challenge in high-resolution manometry: an adjunctive test for detection of esophageal motility disorders. Neurogastroenterol Motil. 2016

Long Y., Huang Z., Deng Y., Chu H., Zheng X., Zhu Y., Fried M., Fox M., Dai N.: Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria. Neurogastroenterol Motil. 2016

Parker H., Tucker E., Hoad C., Pal A., Costigan C., Hudders N., Perkins A., Blackshaw E., Gowland P., Marciani L., Fox M.: Development and validation of a large, modular test meal with liquid and solid components for assessment of gastric motor and sensory function by non-invasive imaging. Neurogastroenterol Motil. 2016 28(4): 554–568

Chu H., Fox M., Zheng X., Deng Y., Long Y., Huang Z., Du L., Xu F, Dai N.: Small intestinal bacterial overgrowth in patients with irritable bowel syndrome: clinical character -istics, psychological factors, and peripheral cytokines. Gastroenterology Research and Practice. 2016

Deng Y., Dai N., Fox M.: Hydrogen Breath Testing With Measurement of Orocecal Transit for Diagnosis of Small Bowel Bacterial Overgrowth. Clin Gastroenterol Hepatol. 2016: 14(10): 1511–1512

Deng Y., Zhu Y., Dai N., Fox M.: Heinrich, H. : Ruminationsyndrom – oft verpasst. Praxis (Bern 1986). 2016: 105(19): 1117–1122

Hollenstein M., Schwizer W., Fox M.: Diagnose ösophagealer Motilitätsstörungen. Der Gastroenterologe, 2016: 11(2): 82–91

Heinrich H., B Misselwitz B., Fox M.: Magen-Darm-Beschwerden in der Schwangerschaft. Hausarzt Praxis, 2016

Amicarella F., Muraro M.G., Hirt C., Cremonesi E., Padovan E., Mele V., Governa V., Han J., Huber X., Droeser R.A., Zuber M., Adamina M., Bolli M., Rosso R., Lugli A., Zlobec I., Terracciano L., Tornillo L., Zajac P., Eppenberger-Castori S., Trapani F., Oertli D., Iezzi G.: Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut. Dec 2015: 0: 1–13

Wölnerhanssen B., Meyer-Gerspach A., Peters T., Beglinger C., Peterli R.: Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls. Surg Obes Relat Dis. Nov 2015: in press 

Wölnerhanssen B., Peterli R.: Management of complications after bariatric surgery. Chirurg. Oct 2015: 86(12): 1114–1120

Stoll L., Füglistaler I.: Organisation ist alles. VSAO Journal: Aug 2015: 4

Gruber M., Füglistaler I., Thumshirn M.: Divertikulose und Divertikulitis: Moderne Therapien für alte Leiden. VSAO Journal: Aug 2015: 4

Schneider J., Peterli R., Gass M., Slawik M., Peters T., Wölnerhanssen B.K.: Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass lead to equal changes in body composition and energy metabolism 17  months postoperatively: a prospective randomized trial. Surg Obes Relat Dis. Jul 2015: in press

Wölnerhanssen B.K., Meyer-Gerspach A.C., Schmidt A., Zimak N., Peterli R., Beglinger C., Borgwardt S.: Dissociable Behavioral, Physiological and Neural Effects of Acute Glucose and Fructose Ingestion: A Pilot Study. PLoS One. Jun 2015: 10: 6

Schulte F., Manz M.:  Colitis ulzerosa – aktuelle Diagnostik und Therapie. Hausarzt Praxis. April 2015: 10(4): 16–20 

Lindinger P., Christe M., Eberle A., Kern B., Peterli R., Peters T., Jayawardene K., Fearnley I., Walker J.: Important mitochondrial proteins in human omental adipose tissue show reduced expression in obesity. Data Brief. Apr 2015: 23(4): 40-3  J Proteomics. Jun 2015: 124: 79–87

Yu YH, Vasselli JR, Zhang Y, Mechanick JI, Korner J, Peterli R.: Metabolic vs. hedonic obesity: A  conceptual distinction and its clinical implications. Obes Rev. 2015 Mar;16(3):234-47. doi: 10.1111/obr.12246. Epub 2015 Jan 14. Review.

Zumstein V., Bolli M., Manz M.: Lighting on PET Scan-Not Always Cancer. J Gastrointest Dig Syst. Jan 2015: 5: 1

Füglistaler I., Stoll L.: Erfahrungen mit einer geteilten Oberarztstelle: Chirurgin und Mutter – das geht! CHAZ.  1/2015: 1–3

Urban S., Manz M., Zettl A., Peters T., Baumann K., von Flüe M.: Gastric Ulcer: An Old Disease – A New Cause. J Gastrointest Dig Syst. Nov 2014: 4: 6
 

Urologie

Bausch K., Bosl M., Matter M., Gabrielli S., Neumayr A.: When You Hear Hoof Beats … Consider Zebras – A Diagnostic Challenge. Travel Med Infect Dis. 2017 Sep; 19: 73–4.

Offermann A., Vlasic I., Syring I., Vogel W., Ruiz C., Zellweger T., Rentsch C., Hagedorn S., Behrends J., Nowak M., Merseburger A., Bubendorf L., Kirfel J., Duensing S., Shaikhibrahim Z., Perner S.: MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling. Oncotarget. 10 Dec 2016

Wetterauer C., Vlajnic T., Schüler J., Gsponer J.R., Thalmann G.N., Cecchini M., Schneider J., Zellweger T., Pueschel H., Bachmann A., Ruiz C., Dirnhofer S., Bubendorf L., Rentsch C.A.: Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immuno-compromised mice. The Prostate. May 2015: 75(6): 585–92

Vedana M., Fuenfschilling M., Tzankov A., Zellweger T.: Primary synovial cell sarcoma of the kidney: case report and review of the literature. Case Rep Oncol. Mar 2015: 8(1): 128–32

Orthopädie/Traumatologie

Weber D. et Weber M.: Corrective osteotomies for malunited malleolar fractures. Foot and Ankle Clinics North America. 2016: 21(1): 37–48